Sulfoprim 15% Premix for Medicated Feed

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

Trimethoprim; Sulfadiazine

제공처:

Univet Limited

ATC 코드:

QJ01EW10

INN (International Name):

Trimethoprim; Sulfadiazine

복용량:

125/25 gram(s)/kilogram(s)

약제 형태:

Premix for medicated feeding stuff

처방전 유형:

POM: Prescription Only Medicine as defined in relevant national legislation

치료 그룹:

Pigs

치료 영역:

sulfadiazine and trimethoprim

치료 징후:

Antibacterial

승인 상태:

Authorised

승인 날짜:

1998-05-01

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Sulfoprim 15% Premix for Medicated Feed
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
3 PHARMACEUTICAL FORM
Premix for Medicated Feed.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For use in the treatment of diseases caused by bacteria sensitive to
potentiated sulphonamide preparations.
4.3 CONTRAINDICATIONS
This product is not recommended for use with any other premix or oral
medication.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Each kg contains
Active Ingredients
Sulphadiazine
125 g
Trimethoprim
25
g
Excipient
Soya bean meal
For a full list of excipients see section 6.1.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_8_
_/_
_0_
_6_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_7_
_0_
_2_
_3_
_5_
_6_
_4_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the
bacteria isolated from the animal.
If this is not possible, therapy
should be based on local (regional, farm level) epidemiological
information about susceptibility of the target bacteria.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO ANIMALS
A dust mask complying with BS2091 or BS6016 must be worn when mixing
the product into the feed.
Wear impervious gloves when handling this product.
Wash all exposed